PROCEPT BioRobotics (PRCT)
(Delayed Data from NSDQ)
$48.12 USD
-1.48 (-2.98%)
Updated Aug 5, 2025 04:00 PM ET
After-Market: $48.12 0.00 (0.00%) 4:54 PM ET
3-Hold of 5 3
F Value F Growth B Momentum F VGM
Fundamental Charts
About Market Cap
As of the previous market close, PROCEPT BioRobotics Corporation has a market cap of $2.74B, which represents its share price of $49.60 multiplied by its outstanding shares number of 55.33M. As a mid-cap company, PRCT's shareholders are generally exposed to less risk than shareholders of small-cap companies but more risk than large-cap companies.
The company's Market Capitalization is a measurement of company size. It is calculation of the company's share price times the number of outstanding shares. Large market cap companies give stability and are good long-term investments. Small market cap companies can produce faster growth and bigger returns, but their stockholders are exposed to more risk.
PRCT 48.12 -1.48(-2.98%)
Will PRCT be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for PRCT based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for PRCT
AxoGen (AXGN) Beats Q2 Earnings and Revenue Estimates
Si-Bone (SIBN) Reports Q2 Loss, Beats Revenue Estimates
PRCT: What are Zacks experts saying now?
Zacks Private Portfolio Services
Envoy Medical, Inc. (COCH) Reports Q2 Loss, Tops Revenue Estimates
Will PROCEPT BioRobotics Corporation (PRCT) Report Negative Earnings Next Week? What You Should Know
PROCEPT BioRobotics Corporation (PRCT) Reports Q1 Loss, Tops Revenue Estimates
Other News for PRCT
Uncovering Potential: PROCEPT BioRobotics's Earnings Preview
Intel reports mixed Q2, FCC approves Skydance-Paramount deal: Morning Buzz
Procept BioRobotics (PRCT) Shares Drop Amid CEO Transition
Procept BioRobotics down after CEO retirement
What You Missed On Wall Street On Friday